AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Fractyl Health, Inc.

$0.61 -$1.64 (-72.82%)
NASDAQ · 14 Sep 2026 20:00 UTC
Previous Close
$0.64
Day Range
$0.58$0.65
Year Range
$0.38$2.44
Market Cap
97.03M
AVG Volume
1.79M
Trailing/Forward PE
-0.56/-
PEG ratio
-0.03
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Revenue (USD)
020K40K60K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q20
26 Q10
25 Q40
25 Q30
25 Q20
25 Q10
24 Q43K
24 Q314K
24 Q243K
24 Q133K
Net Income (USD)
-60M-40M-20M020M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-25.54M
26 Q19.22M
25 Q4-43.73M
25 Q3-45.6M
25 Q2-27.89M
25 Q1-23.73M
24 Q4-24.97M
24 Q3-23.17M
24 Q2-17.23M
24 Q1-3.32M
Operating Income (USD)
-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-19.1M
26 Q1-20.82M
25 Q4-23.28M
25 Q3-22.69M
25 Q2-26.08M
25 Q1-24.76M
24 Q4-25.21M
24 Q3-23.79M
24 Q2-22.98M
24 Q1-21.54M
EBITDA (USD)
-60M-40M-20M020M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2-24.98M
26 Q19.5M
25 Q4-43.45M
25 Q3-45.31M
25 Q2-27.62M
25 Q1-23.45M
24 Q4-24.75M
24 Q3-22.96M
24 Q2-17.04M
24 Q1-3.27M
Cash Flows (USD)
-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-15.9M
26 Q1-22.48M
25 Q4-21.34M
25 Q3-22.72M
25 Q2-21.3M
25 Q1-25.53M
24 Q4-17.27M
24 Q3-18.25M
24 Q2-19M
24 Q1-12.77M
EPS (USD)
-0.8-0.6-0.4-0.2-00.224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS EPS (USD) by quarter
PeriodEPS (USD)
26 Q2-0.16
26 Q10.06
25 Q4-0.29
25 Q3-0.71
25 Q2-0.56
25 Q1-0.49
24 Q4-0.51
24 Q3-0.48
24 Q2-0.36
24 Q1-0.11
Expenses (USD)
010M20M30MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q219.1M
26 Q120.82M
25 Q423.29M
25 Q322.7M
25 Q221.25M
25 Q119.88M
24 Q420.51M
24 Q319.22M
24 Q217.02M
24 Q115.48M
Cash & Debt (USD)
050M100M150MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q247.14M
26 Q163.17M
25 Q481.54M
25 Q377.66M
25 Q222.29M
25 Q142.11M
24 Q467.46M
24 Q384.66M
24 Q2102.44M
24 Q1121.44M
Debt ratios
-0.500.5124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Debt ratios by quarter
PeriodDebt ratios
26 Q2-0.13
26 Q10.02
25 Q40.14
25 Q30.13
25 Q2-0.4
25 Q1-0.22
24 Q40.07
24 Q30.35
24 Q20.75
24 Q10.89
Margins
-300%-200%-100%0%100%23 Q123 Q223 Q323 Q424 Q124 Q224 Q324 Q4
GUTS Margins by quarter
PeriodMargins
24 Q4100%
24 Q350%
24 Q244.19%
24 Q142.42%
23 Q471.43%
23 Q3-202.78%
23 Q234.72%
23 Q140%
Return on Capital
-500%0%500%1000%1500%2000%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Return on Capital by quarter
PeriodReturn on Capital
26 Q21533.81%
26 Q143.12%
25 Q4-462.33%
25 Q31434.96%
25 Q2153.14%
25 Q1-372.31%
24 Q4-87.85%
24 Q3-46.05%
24 Q2-24.35%
24 Q1-3.95%
Shares Outstanding
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Shares Outstanding by quarter
PeriodShares Outstanding
26 Q2158.65M
26 Q1158.49M
25 Q4153.37M
25 Q364.65M
25 Q249.92M
25 Q148.92M
24 Q448.76M
24 Q347.97M
24 Q247.9M
24 Q147.9M
Book Value Per Share (USD)
-101224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q2-0.01
26 Q10.13
25 Q40.06
25 Q3-0.05
25 Q2-0.36
25 Q10.13
24 Q40.58
24 Q31.05
24 Q21.48
24 Q11.76
Total Assets (USD)
050M100M150M200M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
GUTS Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q281.98M
26 Q199.39M
25 Q4121.4M
25 Q3114.27M
25 Q262.01M
25 Q183.04M
24 Q4108.08M
24 Q3126.92M
24 Q2146.44M
24 Q1163.52M
Employee Count
050100150202320242025
GUTS Employee Count by quarter
PeriodEmployee Count
2025100
2024107
2023102
Free Cash Flow Yield
-400%-300%-200%-100%0%med -84.96%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
GUTS Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-81.19%
Sep 26-74.6%
Aug 26-78.85%
Aug 26-66.62%
Aug 26-76.42%
Aug 26-79.22%
Jul 26-80.9%
Jul 26-71.69%
Jul 26-68.42%
Jul 26-69.91%
Jul 26-72.73%
Jun 26-74.59%
Jun 26-64.57%
Jun 26-65.2%
Jun 26-81.67%
May 26-68.74%
May 26-60.93%
May 26-64.4%
May 26-78.52%
May 26-84.74%
Apr 26-95.58%
Apr 26-104.07%
Apr 26-128.82%
Apr 26-129.98%
Mar 26-132.1%
Mar 26-304.27%
Mar 26-288.45%
Mar 26-279.74%
Feb 26-286.12%
Feb 26-286.73%
Feb 26-320.93%
Feb 26-323.56%
Jan 26-291.9%
Jan 26-64.25%
Jan 26-70.3%
Jan 26-67.14%
Jan 26-59.68%
Dec 25-59.15%
Dec 25-61.03%
Dec 25-59.94%
Dec 25-65.82%
Nov 25-85.53%
Nov 25-95.91%
Nov 25-106.57%
Nov 25-149.96%
Oct 25-134.11%
Oct 25-119.53%
Oct 25-127.87%
Oct 25-123.1%
Oct 25-106.42%
Sep 25-123.1%
Sep 25-166.88%
Sep 25-161.72%
Sep 25-178.76%
Aug 25-169.85%
Aug 25-161.72%
Aug 25-161.72%
Aug 25-170.19%
Aug 25-90.4%
Jul 25-85.22%
Jul 25-91.41%
Jul 25-107.64%
Jul 25-99.16%
Jun 25-99.77%
Jun 25-76.46%
Jun 25-79.43%
Jun 25-82.22%
May 25-86.12%
May 25-90.9%
May 25-96.82%
May 25-85.19%
May 25-87.35%
Apr 25-109.53%
Apr 25-113.12%
Apr 25-136.64%
Apr 25-123.22%
Mar 25-111.3%
Mar 25-110.41%
Mar 25-107.82%
Mar 25-97.88%
Feb 25-81.18%
Feb 25-89.18%
Feb 25-80.15%
Feb 25-83.87%
Jan 25-68.83%
Jan 25-60.59%
Jan 25-70.36%
Jan 25-68.45%
Jan 25-57.56%
Dec 24-64.28%
Dec 24-70.75%
Dec 24-62.08%
Dec 24-54.82%
Nov 24-49.47%
Nov 24-60.59%
Nov 24-64.28%
Nov 24-45.36%
Nov 24-39.45%
Oct 24-47.28%
Oct 24-45%
Price to Sales
0200004000060000med 1448.18Jun 24Oct 24Jan 25May 25Aug 25Dec 25Mar 26
GUTS Price to Sales by quarter
PeriodPrice to Sales
Mar 269510.45
Mar 2610031.98
Mar 2610344.47
Feb 2610113.88
Feb 2610092.33
Feb 269016.93
Feb 268943.66
Jan 269913.45
Jan 2645041.56
Jan 2641162.38
Jan 2643101.97
Jan 2648489.71
Dec 2548920.73
Dec 2547412.17
Dec 2548274.2
Dec 2543964.01
Nov 2533835.05
Nov 2530171.38
Nov 2527154.24
Nov 253229.97
Oct 253611.7
Oct 254052.15
Oct 253787.88
Oct 253934.7
Oct 254551.33
Sep 253934.7
Sep 252902.57
Sep 252995.07
Sep 252709.66
Aug 252851.77
Aug 252995.07
Aug 252995.07
Aug 25783.87
Aug 251475.76
Jul 251565.45
Jul 251459.45
Jul 251239.31
Jul 251345.31
Jun 251337.15
Jun 251744.82
Jun 251679.59
Jun 251622.52
May 251549.14
May 251467.61
May 251377.92
May 25849.29
May 25828.32
Apr 25660.56
Apr 25639.59
Apr 25529.49
Apr 25587.16
Mar 25650.07
Mar 25655.32
Mar 25671.04
Mar 25739.2
Feb 25771.54
Feb 25702.3
Feb 25781.43
Feb 25746.81
Jan 25910.02
Jan 251033.67
Jan 25890.24
Jan 25914.97
Jan 251088.07
Dec 24974.32
Dec 24885.29
Dec 241008.94
Dec 241142.47
Nov 241266.12
Nov 241033.67
Nov 24974.32
Nov 24994.21
Nov 241143.14
Oct 24953.96
Oct 241002.26
Oct 24990.19
Oct 24921.76
Sep 241030.44
Sep 241123.02
Sep 241123.02
Sep 241259.87
Aug 241408.8
Aug 241211.57
Aug 24962.01
Aug 24576.06
Aug 24812.31
Jul 241356
Jul 241275.09
Jul 241482.22
Jul 241436.91
Jun 241381.89
Jun 241459.56
Jun 241825.26
Jun 241993.55
May 242181.25
May 242414.26
May 242284.81
May 242455.74
May 242582.69
Apr 242658.07
Price to Book
05101520med 2.53Jun 24Sep 24Dec 24Mar 25Jun 25May 26Aug 26
GUTS Price to Book by quarter
PeriodPrice to Book
Aug 265.19
Jul 265.08
Jul 265.73
Jul 266.01
Jul 265.88
Jul 265.65
Jun 265.51
Jun 266.36
Jun 266.3
Jun 265.03
May 265.98
May 266.74
May 266.38
May 2612.24
May 2611.34
Apr 2610.05
Apr 269.23
Apr 267.46
Apr 267.39
Mar 267.27
Aug 257.38
Aug 2513.89
Jul 2514.73
Jul 2513.74
Jul 2511.66
Jul 2512.66
Jun 2512.58
Jun 2516.42
Jun 2515.81
Jun 2515.27
May 2514.58
May 2513.81
May 2512.97
May 252.78
May 252.71
Apr 252.16
Apr 252.09
Apr 251.73
Apr 251.92
Mar 252.13
Mar 252.14
Mar 252.2
Mar 252.42
Feb 251.49
Feb 251.35
Feb 251.51
Feb 251.44
Jan 251.75
Jan 251.99
Jan 251.72
Jan 251.76
Jan 252.1
Dec 241.88
Dec 241.71
Dec 241.94
Dec 242.2
Nov 242.44
Nov 241.99
Nov 241.88
Nov 241.67
Nov 241.92
Oct 241.6
Oct 241.69
Oct 241.67
Oct 241.55
Sep 241.73
Sep 241.89
Sep 241.89
Sep 242.12
Aug 242.37
Aug 242.04
Aug 241.62
Aug 241.01
Aug 241.43
Jul 242.38
Jul 242.24
Jul 242.61
Jul 242.53
Jun 242.43
Jun 242.57
Jun 243.21
Jun 243.51
May 243.84
May 244.24
May 244.02
Fractyl Health, Inc.
GUTS
Stockpicker

Video analysis: GUTS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: GUTS

Deadline Alert: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

globenewswire.com · 14 Sep 2026

Deadline Alert: Fractyl Health, Inc. (GUTS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Fractyl Health, Inc. (“Fractyl” or the “Company”) (NASDAQ: GUTS) securities between January 13, 2025 and January 29, 2026 inclusive (the “Class Period”).

Levi & Korsinsky Reminds Fractyl Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 20, 2026 - GUTS

globenewswire.com · 14 Sep 2026

Levi & Korsinsky Reminds Fractyl Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 20, 2026 - GUTS

Allegations focus on two public offerings in August and September 2025 that allegedly raised approximately $76.7 million in net proceeds while GUTS shares traded at prices allegedly inflated by the Company's interim Revita data.

GUTS EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Fractyl Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

newsfilecorp.com · 14 Sep 2026

GUTS EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Fractyl Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fractyl To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Fractyl between January 13, 2025 and January 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - September 14, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fractyl Health, Inc. (""Fractyl" or the "Company") (NASDAQ: GUTS) and reminds investors of the October 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com · 14 Sep 2026

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) and certain of its officers.

GUTS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Fractyl Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

newsfilecorp.com · 12 Sep 2026

GUTS UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Fractyl Investors of Securities Class Action Lawsuit Deadline on October 20, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Fractyl To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Fractyl between January 13, 2025 and January 29, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - September 12, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Fractyl Health, Inc. ("Fractyl" or the "Company") (NASDAQ: GUTS) and reminds investors of the October 20, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

feeds.newsfilecorp.com · 11 Sep 2026

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New York, New York--(Newsfile Corp. - September 11, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law

DEADLINE ALERT for AVEX, GUTS, UWMC, HDB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

globenewswire.com · 11 Sep 2026

DEADLINE ALERT for AVEX, GUTS, UWMC, HDB: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions

BENSALEM, Pa., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

globenewswire.com · 11 Sep 2026

Bronstein, Gewirtz & Grossman LLC Urges Fractyl Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Fractyl Health, Inc. (NASDAQ: GUTS) and certain of its officers.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.